Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups
Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559)
11/2007
11/01/2007WO2007070319A3 Dibenzonaphthyridine derivatives and methods of use thereof
11/01/2007WO2007028135A3 Imidazopyridine compounds
11/01/2007WO2005007672A8 Small molecule toll-like receptor (tlr) antagonists
11/01/2007US20070254935 Pyrazole and imidazole compounds and uses thereof
11/01/2007US20070254913 3-Ethyl-6-(1-ethyl-1H-pyrazol-5-yl)-1-(tetrahydro-2H-pyran-4-yl)-1H-pyrazolo[3,4-b]pyridine; adenosine monophosphate activator; antiinflammatory agent, antidepressant, antiallergen, cognition activator, neurodegenerative diseases; arthritis, Alzheimer's disease, schizophrenia, Parkinson disease
11/01/2007US20070254912 Benzimidazolyl-pyridine compounds for inflammation and immune-related uses
11/01/2007US20070254911 Tetrahydro-Pyrazolo[3,4-c]Pyridine Cannabinoid Modulators
11/01/2007US20070254910 Chemokine receptor; antiinflammatory agents; anticancer agents; antiarthritic agents
11/01/2007US20070254909 Novel Pyridine Derivatives, a Process for Their Preparation and a Pharmaceutical Composition Containing the Same
11/01/2007US20070254908 7-azaindoles, pharmaceutical compositions and their therapeutic applications
11/01/2007US20070254905 Pharmaceutical Formulation for Increasing Solubility of 10-Hydroxycamptothecin Compounds in Non-Aqueous Polar Solvents
11/01/2007US20070254904 schizophrenia, emesis, anxiety and depression, irritable bowel syndrome (IBS), circadian rhythm disturbances, pre-eclampsia, nociception, neuropathic pain, pancreatitis, neurogenic inflammation, asthma, chronic obstructive pulmonary disease (COPD) and urinary incontinence
11/01/2007US20070254903 Novel Spiroindoline or Spiroisoquinoline Compounds, Methods of Use and Compositions Thereof
11/01/2007US20070254901 Cancer; 2-(methylthio)-6-phenyl-7-(4-{[4-(5-pyridin-2-yl-4H-1,2,4-triazol-3-yl)piperidin-1-yl]methyl}phenyl)pyrido[2,3-d]pyrimidine;serine/threonine kinase (Akt) suppression; increased cellular potency or solubility, greater selectivity, enhanced pharmacokinetic properties, lack of off target activity
11/01/2007US20070254898 Thienopyrimidine and Thienopyridine Derivatives Substituted with Cyclic Amino Group
11/01/2007US20070254879 Inhibitors of checkpoint kinases
11/01/2007US20070254868 such as 3-(1-(2,3-difluorophenyl)-1H-tetrazol-5-yl)-5-(4-(4-methylpiperazin-1-yl) phenyl)pyridin-2-amine, used as anticarcinogenic agents or for the treatment of atherosclerosis and lung fibrosis
11/01/2007US20070254867 Heterocyclic Kinase Inhibitors
11/01/2007US20070253957 Substituted N-Aryl-1H-Pyrazolo[3,4-B]Quinolin-4-Amines and Analogs as Activators of Caspases and Inducers of Apoptosis
11/01/2007CA2649636A1 Diazepan derivatives modulators of chemokine receptors
11/01/2007CA2649043A1 Azolecarboxamide derivative
11/01/2007CA2648809A1 Indazole compounds and methods for inhibition of cdc7
11/01/2007CA2647077A1 Pyrazolo-tetrahydro pyridine derivatives as orexin receptor antagonists
10/2007
10/31/2007EP1849782A1 Quinolinone derivatives as tyrosine kinase inhibitors
10/31/2007EP1849781A1 Substituted 3-Amino-4-hydroxy pyrrolidines compounds, their preparation and use as medicaments
10/31/2007EP1849469A1 Arylsulfonamide derivatives for use as ccr3 antagonists in the treatment of inflammatory and immunological disorders
10/31/2007EP1848694A1 Heterocyclic substituted phenyl methanones as inhibitors of the glycine transporter 1
10/31/2007EP1848430A2 Novel benzylamine derivatives as cetp inhibitors
10/31/2007EP1848428A2 Thiazole amides, imidazole amides and related analogues
10/31/2007EP1503760A4 Camptothecin derivatives and polymeric conjugates thereof
10/31/2007EP1496896A4 Inhibitors of akt activity
10/31/2007EP1318980B1 Hydroxamate derivatives useful as deacetylase inhibitors
10/31/2007EP1289993B1 Caspase inhibitors and uses thereof
10/31/2007DE102006019597A1 Spirocyclische Cyclohexan-Derivate Spirocyclic cyclohexane derivatives
10/31/2007CN101065380A Preparation of 4,5-dihydro-pyrazolo[3,4-c]pyrid-2-ones
10/31/2007CN101065379A Process for preparing 4,5-dihydro-pyrazolo [3,4-c] pyrid-2-ones
10/31/2007CN101065378A Crystalline forms of a pyrazolo[3,4-c]pyridine factor xa inhibitor
10/31/2007CN101065377A Imidazo[1,2-a]pyridine compounds, compositions, uses and methods related thereto
10/31/2007CN101065374A Substituted dipiperidine ccr2 antagonists
10/31/2007CN101065359A Binuclear metal complex, metal complex dye, photoelectric transducer and photochemical battery
10/31/2007CN101065016A Imidazo{4,5-b}pyrazinone inhibitors of protein kinases
10/31/2007CN100345851C Spiro dihydroindole template compound and its preparing method
10/31/2007CN100345850C Pyridoindolone derivatives substituted in the 3-position by a phenyl, their preparation and their application in therapeutics
10/31/2007CN100345849C Enantiomer (-) of tenatoprazole and the therapeutic use thereof
10/30/2007US7288676 Arylphenyl-substituted cyclic ketoenols
10/30/2007US7288656 Derivatives of N-heterocyclylmethylbenzamides, preparation method thereof and application of same in therapeutics
10/30/2007US7288655 α v integrin receptor antagonists
10/30/2007US7288654 7,8,9,10-Tetrahydropyrido[2,3-b]azocine derivatives; CCR5 chemokine receptor antagonists; prophylactic for lymphadenopathy associated and/or human T-cell leukemia/lymphoma virus infections in peripheral mononuclear blood cells; AIDS; quaternization, oxidation, condensation, deprotecting, amidation
10/30/2007US7288653 6-7-8-9-Tetrahydro-1H-pyrrolo-[3,2-h]-isoquinoline-2,3-dione-3-oxime derivatives such as 5-phenyl-6-7-8-9-tetrahydro-1H-pyrrolo-[3,2-h]-isoquinoline-2,3-dione-3-oxime; sodium channel modulators; antiischemic agents
10/30/2007US7288567 Inhibitors of histone deacetylase
10/30/2007US7288559 Carboxamide spirohydantoin CGRP receptor antagonists
10/30/2007US7288550 Administering 2-butyl-1-[5-(methylsulfonyl)pentyl]-1H-imidazo[4,5-c]quinolin-4-amine or salts to induce biosynthesis of cytokines such as IFN- alpha and/or TNF- alpha; treating viral diseases
10/30/2007US7288549 Heterocyclic compounds, method for preparing same and use thereof as medicines, in particular as antibacterial agents
10/30/2007US7288548 Spiro compounds and methods for the modulation of chemokine receptor activity
10/30/2007US7288540 Phenylalkynes
10/30/2007CA2291509C Process for the preparation of highly chromatic perylene pigments
10/30/2007CA2239227C Nitrogen-containing heterocyclic compounds
10/30/2007CA2179650C Bisindolemaleimides and their use as protein kinase c inhibitors
10/25/2007WO2007120591A1 Process for the preparation of cgrp antagonist
10/25/2007WO2007120590A2 Process for the preparation of pyridine heterocycle cgrp antagonist intermediate
10/25/2007WO2007119889A1 Novel piperazine compound, and use thereof as hcv polymerase inhibitor
10/25/2007WO2007119588A1 Brain function-improving agent, and functional food containing the improving agent
10/25/2007WO2007119463A1 2-(cyclic amino)-pyrimidone derivatives as tpk1 inhibitors
10/25/2007WO2007118314A1 1,5 and 3,6- substituted indole compounds having nos inhibitory activity
10/25/2007WO2007097981A3 Alpha carbolines and uses thereof
10/25/2007WO2007076070A3 Modulators of muscarinic receptors
10/25/2007WO2007038610A3 Use of natural products for treatment of neurological disorders
10/25/2007WO2007005779A3 Antiviral agents
10/25/2007WO2002048116A3 Inhibitors of hepatitis c virus ns3 protease
10/25/2007US20070249663 Corticotropin-Releasing Factor (CRF) receptor antagonist as therapeutic agent for depression, depressive symptom, or irritable bowel syndrome
10/25/2007US20070249662 5-methoxy-2-{[(4-methoxy-3,5-dimethyl-2-pyridinyl)methyl]sulfanyl}-1H-benzimidazole; chemical intermediates for safer oxidation of the thioether intermediate to give the sulfinyl derivative, omeprazole; ("prazoles", antisecretory agents); by-product inhibition
10/25/2007US20070249661 Compounds for inflammation and immune-related uses
10/25/2007US20070249659 melanin concentrating hormone receptor antagonist; preventing or treating vascular system diseases, nervous system disorders, metabolic disorders, urogenital diseases, respiratory diseases disorders; N-(2-ethyl-3-methylimidazo[1,2-a]pyridin-6-yl)-3-fluoro-4-(pyridin-2-ylmethoxy)benzamide
10/25/2007US20070249657 1-Aza-Bicyclo3.3.1Nonanes
10/25/2007US20070249653 Tetracyclic benzamide derivatives and methods of use thereof
10/25/2007US20070249652 Phenanthridinium Derivatives as Dna Binding Agents
10/25/2007US20070249648 Novel Diazaspiroalkanes and Their Use for Treatment of Ccr8 Mediated Diseases
10/25/2007US20070249638 Derivatives of triazoly-imidazopyridine and of the triazolypurines useful as ligands of the adenosine A2a receptor and their use as medicaments
10/25/2007US20070249631 e.g. 3 fluoro N [6 (4 fluoro benzoyl)5,6,7,8 tetrahydro pyrido[4,3 d]pyrimidin 2yl]benzamide; analgesics; neuropathic pain; side effect reduction
10/25/2007US20070249624 4-squarylpiperazine derivatives such as 3-(1-Piperazinyl)-4-(2-thienyl)-cyclobut-2-ene-1,2-dione with other an AIDS antiviral agent, antiinfective agent, an immunomodulator, and HIV entry inhibit; viricide; human immunodeficiency virus-1 (HIV) and acquired immunodeficiency syndrome (AIDS)
10/25/2007US20070249618 Novel Piperidine Derivatives as Histamine H3 Receptor Ligands for Treatment of Depression
10/25/2007US20070249616 Substituted 1-Benzyl-4-Substituted Piperazine Analogues
10/25/2007US20070249612 Substituted 2H-[1,2,4]Triazolo[4,3-A]Pyrazines as Gsk-3 Inhibitors
10/25/2007US20070249601 Compounds and therapeutical use thereof
10/25/2007US20070249600 Chemical compounds
10/25/2007US20070249587 Aromatic-Ring-Fused Pyrimidine Derivative
10/25/2007US20070249579 Diketo-piperazine and piperidine derivatives as antiviral agents
10/25/2007US20070248614 Vaccination
10/25/2007US20070247063 Light-Emitting Device Material and Light-Emitting Device
10/25/2007CA2711638A1 3-substituted-8-hydroxypyridino[1,2-a]pyrimidin-4-one compounds and their use in treating retinal degenerative diseases
10/25/2007CA2649315A1 Brain function-improving agent, and functional food containing the improving agent
10/25/2007CA2649159A1 Process for the preparation of cgrp antagonist
10/25/2007CA2649158A1 Process for the preparation of pyridine heterocycle cgrp antagonist intermediate
10/25/2007CA2644979A1 2-(cyclic amino)-pyrimidone derivatives as tpk1 inhibitors
10/25/2007CA2643822A1 1,5 and 3,6- substituted indole compounds having nos inhibitory activity
10/24/2007EP1847538A1 A process for the preparation of pyridine compounds
10/24/2007EP1847263A2 Inhibitors against the production and release of inflammatory cytokines
10/24/2007EP1846407A1 7-{4-[2-(2,6-dichloro-4-methylphenoxy)ethoxy]phenyl}-3,9-diazabicyclo[3.3.31]non-6-ene-6-carboxylic acid cyclopropyl-(2,3-dimethylbenzyl)amide as inhibitors of renin for the treatment of hypertension.
10/24/2007EP1846406A1 Maleimide derivatives, pharmaceutical compositions and methods for treatment of cancer
10/24/2007EP1846405A2 Oxime and hydroxylamine substituted imidazo 4,5-c ring compounds and methods
1 ... 255 256 257 258 259 260 261 262 263 264 265 266 267 268 269 270 271 272 273 274 275 ... 646